| 名称: | |
| 描述: | |
| 公开/私有: | 公开 私有 |
标签:
用空格间隔多个标签,如:小说 文学 余秋雨
保存至书单:
封面仅供参考
Identification of biomarkers, new treatments, and vaccines for COVID-19 / |
|
|
ISBN/ISSN:
|
9783030716967 价格： CNY1431.85 |
|
ISBN/ISSN:
|
3030716961 |
|
科图分类法:
|
R512.93 |
|
题名:
|
Identification of biomarkers, new treatments, and vaccines for COVID-19 / |
|
出版发行:
|
Cham : Springer, 2021. |
|
载体形态:
|
229 pages ; ; 22 cm. |
|
附注:
|
Includes index. |
|
内容提要:
|
The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just one year. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as diabetes and obesity. As the cases and death rate remain high, there are justified fears of this virus remaining for several months or years to come. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these begin to be deployed and administered across the globe, many now feel the virus will be brought under control and lives will eventually return to normal. This new volume will increase readers understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers. |
|
主题词:
|
Biochemical markers. |
|
主题词:
|
COVID-19 (Disease) |
|
主要责任者:
|
Guest, Paul C., |
|
标签:
|
|
|
相关资源:
|
|
限定所在馆:
限定所在馆藏地点:
限定馆藏状态:
预约：可预约已外借图书，在馆图书不可预约
>>
HEA| |02653nam a2200313 450 001| |022022007090 008| |210724s2021 sz 001 0 eng d 020| |▼a9783030716967▼cCNY1431.85 020| |▼a3030716961 040| |▼aEBLCP▼beng▼cCNPIEC▼erda▼dYDX- | |▼dEBLCP▼dGW5XE▼dOCLCO 049| |▼aMAIN 072| 7|▼aMED052000▼2bisacsh 082|04|▼a610.28▼223 090| |▼aR512.93▼b227393 245|00|▼aIdentification of biomarkers- | |, new treatments, and vaccines- | | for COVID-19 /▼cPaul C. Guest, editor. 260| 1|▼aCham :▼bSpringer,▼c2021. 300| |▼a229 pages ;▼c22 cm. 336| |▼atext▼2rdacontent 337| |▼aunmediated▼2rdamedia 338| |▼avolume▼2rdacarrier 490|1 |▼aAdvances in Experimental Med- | |icine and Biology ;▼vv.1327 490|1 |▼aAdvances in experimental med- | |icine and biology. Proteomics,- | | metabolomics, interactomics a- | |nd systems biology 500| |▼aIncludes index. 520| |▼aThe novel coronavirus 2019 (- | |COVID-19) has caused a serious- | | global pandemic in just one y- | |ear. Nearly every country and - | |territory in the world has bee- | |n affected by the virus. The v- | |irulence and infection rate of- | | the virus are profound, and h- | |as required extreme social dis- | |tancing measures across the gl- | |obe in order to prevent overwh- | |elming the healthcare services- | | and hospitals. COVID-19 appea- | |rs to have the greatest effect- | |s on elderly individuals and t- | |hose who have co-morbid diseas- | |es, such as diabetes and obesi- | |ty. As the cases and death rat- | |e remain high, there are justi- | |fied fears of this virus remai- | |ning for several months or yea- | |rs to come. To address this, a- | | rapid and unprecedented world- | |wide mobilization effort has b- | |egun to identify effective tre- | |atments and develop vaccines. - | |As these begin to be deployed - | |and administered across the gl- | |obe, many now feel the virus w- | |ill be brought under control a- | |nd lives will eventually retur- | |n to normal. This new volume w- | |ill increase readers understan- | |ding of the ongoing COVID-19 p- | |andemic through a series of ch- | |apters that address these conc- | |erns. Leading experts will dis- | |cuss new treatment approaches,- | | vaccine development, mental h- | |ealth aspects of the pandemic,- | | and convey the results of sur- | |vey studies. The book will be - | |an excellent resource for rese- | |archers studying virology, met- | |abolic diseases, respiratory d- | |isorders, and clinical scienti- | |sts, physicians, drug companie- | |s, and healthcare services and workers. 650| 0|▼aBiochemical markers. 650| 0|▼aCOVID-19 (Disease) 700|1 |▼aGuest, Paul C.,▼eeditor. 830| 0|▼aAdvances in experimental med- | |icine and biology ;▼vv. 1327. 830| 0|▼aAdvances in experimental med- | |icine and biology.▼pProteomics- | |, metabolomics, interactomics - | |and systems biology.